Manchester Capital Management’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $127 | Hold |
1
| – | – | ﹤0.01% | 1183 |
|
2025
Q1 | $128 | Hold |
1
| – | – | ﹤0.01% | 1150 |
|
2024
Q4 | $133 | Hold |
1
| – | – | ﹤0.01% | 1136 |
|
2024
Q3 | $146 | Hold |
1
| – | – | ﹤0.01% | 1150 |
|
2024
Q2 | $138 | Buy |
+1
| New | +$138 | ﹤0.01% | 1126 |
|
2023
Q2 | – | Sell |
-75
| Closed | -$9.69K | – | 1048 |
|
2023
Q1 | $9.69K | Hold |
75
| – | – | ﹤0.01% | 548 |
|
2022
Q4 | $9.85K | Hold |
75
| – | – | ﹤0.01% | 467 |
|
2022
Q3 | $9K | Hold |
75
| – | – | ﹤0.01% | 455 |
|
2022
Q2 | $9K | Hold |
75
| – | – | ﹤0.01% | 493 |
|
2022
Q1 | $10K | Hold |
75
| – | – | ﹤0.01% | 540 |
|
2021
Q4 | $11K | Hold |
75
| – | – | ﹤0.01% | 555 |
|
2021
Q3 | $12K | Hold |
75
| – | – | ﹤0.01% | 572 |
|
2021
Q2 | $12K | Hold |
75
| – | – | ﹤0.01% | 486 |
|
2021
Q1 | $11K | Sell |
75
-70
| -48% | -$10.3K | ﹤0.01% | 476 |
|
2020
Q4 | $22K | Hold |
145
| – | – | ﹤0.01% | 417 |
|
2020
Q3 | $20K | Hold |
145
| – | – | ﹤0.01% | 382 |
|
2020
Q2 | $20K | Buy |
+145
| New | +$20K | ﹤0.01% | 423 |
|